Department of Medical Oncology and Pneumology, University Hospital of Tübingen, Otfried-Müller-Strasse 14, 72076, Tübingen, Germany.
School of Pharmacy, University of Eastern Finland, Kuopio, 70211, Finland.
ChemMedChem. 2021 Aug 19;16(16):2524-2534. doi: 10.1002/cmdc.202100246. Epub 2021 May 18.
Dengue is a tropical disease caused by the dengue virus (DENV), with an estimate of 300 million new cases every year. Due to the limited vaccine efficiency and absence of effective antiviral treatment, new drug candidates are urgently needed. DENV NS3-NS2B protease complex is essential for viral post-translational processing and maturation, and this enzyme has been extensively studied as a relevant drug target. Crystal structures often underestimate NS3-NS2B flexibility, whereas they can adopt different conformational states depending on the bound substrate. We conducted molecular dynamics simulations (∼30 μs) with a non- and covalently bound inhibitor to understand the conformational changes in the DENV-3 NS3-NS2B complex. Our results show that the open-closing movement of the protease exposes multiple druggable subpockets that can be investigated in later drug discovery efforts.
登革热是一种由登革病毒(DENV)引起的热带疾病,估计每年有 3 亿例新发病例。由于疫苗效率有限且缺乏有效的抗病毒治疗方法,因此迫切需要新的药物候选物。DENV NS3-NS2B 蛋白酶复合物是病毒翻译后加工和成熟所必需的,该酶已被广泛研究作为相关的药物靶标。晶体结构通常低估了 NS3-NS2B 的灵活性,而它们可以根据结合的底物采用不同的构象状态。我们使用非共价和共价结合抑制剂进行了分子动力学模拟(约 30μs),以了解 DENV-3 NS3-NS2B 复合物的构象变化。我们的结果表明,蛋白酶的开闭运动暴露了多个可成药的亚口袋,可在以后的药物发现工作中进行研究。